Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Mar 13;189(10):E398–E404. doi: 10.1503/cmaj.160771

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 Joule Inc. or its licensors

PMC Copyright notice

Figure 2: — Comparison of ⁶⁸Ga-DOTATATE PET/CT and ¹⁸FDG PET/CT for detection of poorly and well-differentiated neuroendocrine tumours. ⁶⁸Gallium radiolabelled somatostatin analogue PET/CT is more sensitive for identifying well-differentiated tumours in which the somatostatin receptor expression is preserved on neuroendocrine cells. ¹⁸FDG PET/CT is more sensitive for identifying poorly differentiated tumours in which the somatostatin receptor expression has been lost. Please note that the comparison images are from from different patients to illustrate differences in detail by modality based on the differentiation of the tumour. Images provided by Dr. David Chan (Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.). FDG = fluorodeoxyglucose, PET/CT = positron emission tomography–computed tomography.